<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200520047521N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-30</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of transcranial direct current stimulation (TDCS) in the patients with post – stroke dysphagia</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effectiveness of transcranial direct current stimulation (TDCS) on the swallowing function of the patients with post – stroke dysphagia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-11-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51098</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Stratified randomisation using permuted blocked randomisation in each group.
With random allocation software. 
Severity of dysphagia and severity of stroke will be used for grouping. 
Using sealed envelopes by a secretary for concealment, Blinding description: Blinding participants/ families/ caregivers: All participants will receive behavioral swallowing therapy and TDCS stimulation. For the sham group (control group) the same montage of TDCS will be performed. The only difference is that the real group (experimental group) will receive 20 minutes of TDCS stimulation while the sham group will receive the current only for 30 seconds at the begining and the end of the period . 
Blinding care providers (speech therapist, and stroke physicians), investigators and outcome assessor: The TDCS technician will be trained and employed to deliver the TDCS . The technician will be independent of the investigators and will be unaware of the study’ methodology. The secretary will inform them about the group of the patients (real or sham TDCS) in a sealed envelope. Therefore, the only persons who will know the group of the patients (sham or real) will be the secretary and the technician of TDCS.</study_design>
      <phase>N/A</phase>
      <hc_freetext>DYSPHAGIA POST- STROKE.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: TDCS  online with classic (behavioral) swallowing therapy for 20 minutes in five therapy sessions (1 session each day). Intervention 2: Control group: Sham TDCS  online with classic (behavioural) swallowing therapy for 20 minutes in five therapy sessions (1 session each day).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All participant data will be shared after the encoding including age, sex, dysphagia severity, test results and research implementation method.

When:
Six month after publication the results will be shared.

To whom:
All researchers.

Conditions:
To use in meta- analysis studies or citation data in other relevant studies.

Where to obtain:
Sima Farpour
email: sima.farpour@gmail.com
Mobile: 0098 9173177636

How to obtain:
By formal request via email and the purpose of using data, the information will be sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sima Farpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Elahiye building, Shahis Shekooh Ave, Shahid Fatemifar St, Farhangshahr Blv.</address>
        <city>SHIRAZ</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7184839363</zip>
        <telephone>+98 71 3639 9507</telephone>
        <email>sima.farpour@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sima Farpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Elahiye building, shahis shekooh st, shahid Fatemifar St, Farhangshahr Blv.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7184839363</zip>
        <telephone>+98 71 3639 9507</telephone>
        <email>sima.farpour@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 years or over.
Presence of  ischemic stroke confirmed with brain imaging.
diagnosis of dysphagia according to Northwestern Dysphagia Patient Checksheet Screening tool (NDPCS).</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Hemorrhagic or Lacunar stroke.
Previous history of dysphagia.
Presence of neurological disorders other than stroke or neurodegenerative disorders.
Auditory and Visual Condition  interfering with a speech therapist or assessor orTDCS technician s instruction
History of seizures.
Those with a cardiac pacemaker or metallic implants.
Previous history of skull surgery or current need of skull surgery.
Presence of a tracheal cannula.
Unstable medical condition which can interfere with the study process (such as hemodynamic instability, decreased level of consciousness, etc.)
Inability to stay alert during the treatment.
This study was done during the COVID- 19 pandemic. For the safety of both patients and the research group, none of the patients recruited for the study had active SARS- COV- 2 infections or a history of infection in the last 14 days.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R13</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Aphagia and dysphagia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: TDCS  online with classic (behavioral) swallowing therapy for 20 minutes in five therapy sessions (1 session each day)</i_keyword>
      <i_keyword>Control group: Sham TDCS  online with classic (behavioural) swallowing therapy for 20 minutes in five therapy sessions (1 session each day)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The feeding status of the patient with the Functional Oral Intake Scale (FOIS). Timepoint: before intervention, one day after the last day of intervention, one month after intervention. Method of measurement: Functional Oral Intake Scale (FOIS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The severity of dysphagia and aspiration. Timepoint: before intervention, one day after the last day of intervention, one month after intervention. Method of measurement: The MANN assessment of swallowing ability (MASA).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-09-07</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman neuroscience research center, No.1 Alley, Jahad Ave., Somayye crossroad Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
